D

DiagnaMed Holdings Corp
CNSX:DMED

Watchlist Manager
DiagnaMed Holdings Corp
CNSX:DMED
Watchlist
Price: 0.075 CAD Market Closed
Market Cap: CA$8.6m

DiagnaMed Holdings Corp
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

DiagnaMed Holdings Corp
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
D
DiagnaMed Holdings Corp
CNSX:DMED
Free Cash Flow
-CA$336.1k
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Enerflex Ltd
TSX:EFX
Free Cash Flow
CA$230m
CAGR 3-Years
N/A
CAGR 5-Years
22%
CAGR 10-Years
N/A
T
TerraVest Industries Inc
TSX:TVK
Free Cash Flow
CA$96.4m
CAGR 3-Years
81%
CAGR 5-Years
13%
CAGR 10-Years
22%
CES Energy Solutions Corp
TSX:CEU
Free Cash Flow
CA$183.7m
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
2%
Secure Energy Services Inc
TSX:SES
Free Cash Flow
CA$48m
CAGR 3-Years
-47%
CAGR 5-Years
-9%
CAGR 10-Years
11%
H
HydroGraph Clean Power Inc
CNSX:HG
Free Cash Flow
-$4.9m
CAGR 3-Years
3%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
No Stocks Found

DiagnaMed Holdings Corp
Glance View

Market Cap
8.6m CAD
Industry
N/A

DiagnaMed Holdings Corp. is a biotechnology company, which engages in the development and commercialization of digital therapeutics for mental health and neurological disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm is developing a platform of software-based prescription digital therapeutic products (PDT Products) for detecting brain age and tremors for neurological disorders. Its PDT products include BrainYear and BrainTremor. BrainYear is an electroencephalogram-based (EEG) machine-learning solution to detect an individual’s brain age for use in clinic and at-home. BrainTremor is a wearable device to detect tremors and brain activity for neurological disorders by EEG. The firm is also conducting research and development of digital therapeutics applications with the intent to commercialize its PDT Products in the United States. The company also outsources its research and development in the United States and Canada.

DMED Intrinsic Value
0.002 CAD
Overvaluation 98%
Intrinsic Value
Price CA$0.075
D

See Also

What is DiagnaMed Holdings Corp's Free Cash Flow?
Free Cash Flow
-336.1k CAD

Based on the financial report for Sep 30, 2025, DiagnaMed Holdings Corp's Free Cash Flow amounts to -336.1k CAD.

What is DiagnaMed Holdings Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
25%

Over the last year, the Free Cash Flow growth was 24%. The average annual Free Cash Flow growth rates for DiagnaMed Holdings Corp have been 25% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett